PerkinElmer to acquire Oxford Immunotec for $591m to expand tuberculosis testing capabilities

In a significant move within the diagnostics sector, US-based PerkinElmer has announced its agreement to acquire UK-based Oxford Immunotec for $591 million, translating to $22 ... Read More